Homoeopathic medicines for uncontrolled high blood in menopausal women.

A series of N-of-1 trials exploring the efficacy of individualized homoeopathic medicines in LM potencies along with standard of care in the treatment of resistant hypertension in post-menopausal women. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/09/094251

Enrollment

Registered

2025-09-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Individualized homeopathic medication plus Standard care with Concomittant care: Individualized homeopathic medication (IHM) following the method of the sixth edition of the Organon is

15 doses to be marked on the vial

each dose of 5 ml to be taken after 10 uniformly forceful downward strokes to the vial in 45 ml normal water in a clean cup, to stir well, to take 5 ml of this liquid orally, and to discard rest of th

Eligibility

Inclusion criteria

Inclusion criteria: 1. Postmenopausal women with age group of 45-60 yrs of age. 2. Diagnosed cases of essential hypertension with blood pressure range, Systolic: 140- 159mmhg, Diastolic: 90-99mmhg 3. Patients on concurrent use of antihypertensive medications.

Exclusion criteria

Exclusion criteria: 1. Failing to give written, informed consent/assent before participating 2. Postmenopausal Hypertension cases associated with complications like kidney disease, heart diseases, stroke etc. and severe concurrent illness 3. Cases with autoimmune disorders 4. Immunocompromised individuals 5. Cases with substance abuse and /or dependence. 6. Patient undergoing any hormonal replacement therapy, using contraceptive pills or history of their use in previous 3 months. 7. Those who are too ill to get consultation. 8. Diagnosed cases of uncontrolled or potentially fatal illnesses impacting quality of life, such as unstable mental or psychiatric illnesses. 9. Receiving homoeopathic treatment within the last six months for any chronic illness. 10. Concurrent involvement in any other clinical study.

Design outcomes

Primary

Measure	Time frame
Difference in systolic blood pressure (SBP) and diastolic blood pressure (DBP)Timepoint: At Baseline every 17 days up to 4 months	—

Secondary

Measure	Time frame
Mini Questionnaire of Quality of Life in Hypertension (MINICHAL) QuestionnaireTimepoint: At Baseline every 17 days up to 4 months;Medical Outcomes Study Questionnaire Short Form 12 (SF-12) QuestionnaireTimepoint: At Baseline every 17 days up to 4 months;Serum Urea, uric acid, creatinine, urine R/E, Lipid profile & ECGTimepoint: At Baseline every 17 days up to 4 months	—

Countries

India

Contacts

Public ContactShubhamoy Ghosh

D.N.De Homoeopathic Medical College and Hospital Government of West Bengal

urvashidiwakar1@gmail.com8130907217

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026